DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement

Core Insights - DaVita is making significant progress in value-based kidney care, demonstrating improved outcomes for patients with kidney disease through coordinated care models and partnerships with major insurers [2][3][4]. Group 1: Value-Based Care Progress - DaVita has invested in care innovation for over two decades, focusing on value-based models that provide comprehensive, longitudinal care rather than episodic treatment [3][6]. - The Comprehensive Kidney Care Contracting (CKCC) option within CMMI's Kidney Care Choices model shows year-over-year improvements, indicating the model's maturation and effectiveness [4][5]. - Patients involved in CKCC and related programs are experiencing better health outcomes due to enhanced care coordination and collaboration among healthcare teams [5][8]. Group 2: Financial and Operational Metrics - DaVita manages over $5 billion in medical costs under value-based care arrangements, which are linked to higher transplant rates and improved patient understanding of their conditions [6][7]. - The company has achieved over $200 million in shared savings since the inception of the program, reflecting its efficiency and effectiveness in care delivery [7]. - DaVita's Total Quality Score improved by 9%, driven by better treatment starts and patient engagement, alongside reduced missed treatments and lower rates of central venous catheter use [7]. Group 3: Long-Term Sustainability and Innovation - DaVita's integrated kidney care programs are showing signs of financial sustainability while also improving patient outcomes, suggesting a model that could be replicated for other chronic conditions [8]. - The company emphasizes the importance of continued investment in coordinated care to drive healthcare innovation and improve patient experiences [8].